Kedrion Biopharma extends its focus on patients by offering Mix2Vial
Mar 28, 2016 |
CORPORATE
A needle-free, double-ended, all plastic filter transfer set for use in reconstituting Koate®-DVI
CURhE, Global Alliance for mother and child healthcare
Mar 08, 2016 |
CORPORATE
Kedrion among the founding members with a goal of Rh disease eradication
Kedrion Biopharma Expands Immunoglobulin Therapies Portfolio
Jan 19, 2016 |
CORPORATE
Gains Commercial Rights in the U.S. to BIVIGAM®, a Recently Approved IGIV Brand
KEDPlasma welcomes donors to its new Augsburg collection center
Jul 19, 2015 |
CORPORATE
Plasma collected in Germany is essential to Kedrion Biopharma’s European plasma-derived therapies
Humanitarian programme augments access to clotting factors in developing countries
Jun 28, 2015 |
CORPORATE
Kedrion helps the WISH project come true: Italian CNS[NM1] and the World Federation of Hemophilia sign agreement in London
Kedrion employees in the US volunteer to help others
Feb 18, 2015 |
CORPORATE
Leaving every place we visit a little better than when we arrived: this is Kedrion Cares
Licenses for RhoGAM® and MICRhoGAM® transferred to Kedrion
Feb 17, 2015 |
CORPORATE
This is a milestone in consolidating our portfolio of plasma-derived products